United States Dry Powder Inhaler Device Market Report 2016

December 2016 | 104 pages | ID: U3E6C3FB9EAEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Dry Powder Inhaler Device

Revenue, means the sales value of Dry Powder Inhaler Device

This report studies sales (consumption) of Dry Powder Inhaler Device in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bayer HealthCare AG Company
• GlaxoSmithKline Plc
• Sandoz International GmbH
• Teva Pharmaceutical Industries Ltd.
• Decartis AG
• AKELA Pharma Inc.
• Pharmaxis Limited

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Dry Powder Inhaler Device in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Dry Powder Inhaler Device Market Report 2016

1 DRY POWDER INHALER DEVICE OVERVIEW

1.1 Product Overview and Scope of Dry Powder Inhaler Device
1.2 Classification of Dry Powder Inhaler Device
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Dry Powder Inhaler Device
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Dry Powder Inhaler Device (2011-2021)
  1.4.1 United States Dry Powder Inhaler Device Sales and Growth Rate (2011-2021)
  1.4.2 United States Dry Powder Inhaler Device Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRY POWDER INHALER DEVICE COMPETITION BY MANUFACTURERS

2.1 United States Dry Powder Inhaler Device Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Dry Powder Inhaler Device Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Dry Powder Inhaler Device Average Price by Manufactures (2015 and 2016)
2.4 Dry Powder Inhaler Device Market Competitive Situation and Trends
  2.4.1 Dry Powder Inhaler Device Market Concentration Rate
  2.4.2 Dry Powder Inhaler Device Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRY POWDER INHALER DEVICE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Dry Powder Inhaler Device Sales and Market Share by Type (2011-2016)
3.2 United States Dry Powder Inhaler Device Revenue and Market Share by Type (2011-2016)
3.3 United States Dry Powder Inhaler Device Price by Type (2011-2016)
3.4 United States Dry Powder Inhaler Device Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DRY POWDER INHALER DEVICE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Dry Powder Inhaler Device Sales and Market Share by Application (2011-2016)
4.2 United States Dry Powder Inhaler Device Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DRY POWDER INHALER DEVICE MANUFACTURERS PROFILES/ANALYSIS

5.1 Bayer HealthCare AG Company
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bayer HealthCare AG Company Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline Plc
  5.2.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GlaxoSmithKline Plc Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sandoz International GmbH
  5.3.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sandoz International GmbH Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Teva Pharmaceutical Industries Ltd.
  5.4.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Teva Pharmaceutical Industries Ltd. Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Decartis AG
  5.5.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Decartis AG Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 AKELA Pharma Inc.
  5.6.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 AKELA Pharma Inc. Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Pharmaxis Limited
  5.7.2 Dry Powder Inhaler Device Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Pharmaxis Limited Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 DRY POWDER INHALER DEVICE MANUFACTURING COST ANALYSIS

6.1 Dry Powder Inhaler Device Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Dry Powder Inhaler Device

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Dry Powder Inhaler Device Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Dry Powder Inhaler Device Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DRY POWDER INHALER DEVICE MARKET FORECAST (2016-2021)

10.1 United States Dry Powder Inhaler Device Sales, Revenue Forecast (2016-2021)
10.2 United States Dry Powder Inhaler Device Sales Forecast by Type (2016-2021)
10.3 United States Dry Powder Inhaler Device Sales Forecast by Application (2016-2021)
10.4 Dry Powder Inhaler Device Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Dry Powder Inhaler Device
Table Classification of Dry Powder Inhaler Device
Figure United States Sales Market Share of Dry Powder Inhaler Device by Type in 2015
Table Application of Dry Powder Inhaler Device
Figure United States Sales Market Share of Dry Powder Inhaler Device by Application in 2015
Figure United States Dry Powder Inhaler Device Sales and Growth Rate (2011-2021)
Figure United States Dry Powder Inhaler Device Revenue and Growth Rate (2011-2021)
Table United States Dry Powder Inhaler Device Sales of Key Manufacturers (2015 and 2016)
Table United States Dry Powder Inhaler Device Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Dry Powder Inhaler Device Sales Share by Manufacturers
Figure 2016 Dry Powder Inhaler Device Sales Share by Manufacturers
Table United States Dry Powder Inhaler Device Revenue by Manufacturers (2015 and 2016)
Table United States Dry Powder Inhaler Device Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Dry Powder Inhaler Device Revenue Share by Manufacturers
Table 2016 United States Dry Powder Inhaler Device Revenue Share by Manufacturers
Table United States Market Dry Powder Inhaler Device Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Dry Powder Inhaler Device Average Price of Key Manufacturers in 2015
Figure Dry Powder Inhaler Device Market Share of Top 3 Manufacturers
Figure Dry Powder Inhaler Device Market Share of Top 5 Manufacturers
Table United States Dry Powder Inhaler Device Sales by Type (2011-2016)
Table United States Dry Powder Inhaler Device Sales Share by Type (2011-2016)
Figure United States Dry Powder Inhaler Device Sales Market Share by Type in 2015
Table United States Dry Powder Inhaler Device Revenue and Market Share by Type (2011-2016)
Table United States Dry Powder Inhaler Device Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Dry Powder Inhaler Device by Type (2011-2016)
Table United States Dry Powder Inhaler Device Price by Type (2011-2016)
Figure United States Dry Powder Inhaler Device Sales Growth Rate by Type (2011-2016)
Table United States Dry Powder Inhaler Device Sales by Application (2011-2016)
Table United States Dry Powder Inhaler Device Sales Market Share by Application (2011-2016)
Figure United States Dry Powder Inhaler Device Sales Market Share by Application in 2015
Table United States Dry Powder Inhaler Device Sales Growth Rate by Application (2011-2016)
Figure United States Dry Powder Inhaler Device Sales Growth Rate by Application (2011-2016)
Table Bayer HealthCare AG Company Basic Information List
Table Bayer HealthCare AG Company Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare AG Company Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table Sandoz International GmbH Basic Information List
Table Sandoz International GmbH Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz International GmbH Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table Decartis AG Basic Information List
Table Decartis AG Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Decartis AG Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table AKELA Pharma Inc. Basic Information List
Table AKELA Pharma Inc. Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table AKELA Pharma Inc. Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table Pharmaxis Limited Basic Information List
Table Pharmaxis Limited Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pharmaxis Limited Dry Powder Inhaler Device Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dry Powder Inhaler Device
Figure Manufacturing Process Analysis of Dry Powder Inhaler Device
Figure Dry Powder Inhaler Device Industrial Chain Analysis
Table Raw Materials Sources of Dry Powder Inhaler Device Major Manufacturers in 2015
Table Major Buyers of Dry Powder Inhaler Device
Table Distributors/Traders List
Figure United States Dry Powder Inhaler Device Production and Growth Rate Forecast (2016-2021)
Figure United States Dry Powder Inhaler Device Revenue and Growth Rate Forecast (2016-2021)
Table United States Dry Powder Inhaler Device Production Forecast by Type (2016-2021)
Table United States Dry Powder Inhaler Device Consumption Forecast by Application (2016-2021)